|
MRI News Service:
'Cation' p19 |
|
|
|
 |
 | | | ''Baltimore, MD - The publication of a negative phase 2 trial of an investigational compound for reperfusion injury has prompted discussion about how best to assess the efficacy of agents for this indication in the future [1]. The FX06 in Ischemia and ...' | | Friday, 30 January 2009 by www.theheart.org |
|
|
|
| | | ''Authorisation Application (MAA) for Sinerem, a new contrast agent for MRI. The Sinerem MAA had been submitted to the EMEA (European Medicines Agency) in November 2006 for the detection and characterisation of metastatic lymph nodes in pelvic ...' | | | Saturday, 13 December 2008 by www.prnewswire.co.uk | |
|
|
|
| | | ''MELVILLE, NEW YORK, December 1, 2008 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, today announced that The NASDAQ Listing Qualifications Panel ('NASDAQ Panel') has granted the Company's request for continued listing on The NASDAQ ...' | | | Monday, 1 December 2008 by www.fonar.com | |
|
|
|
| | | ''CHICAGO--(BUSINESS WIRE)--Hitachi Medical Systems America, recognized as an innovator in patient-friendly MR solutions, will highlight advanced high-field clinical applications for OASIS™ 1.2T and Echelon™ XLS 1.5T. Showcased will be advances in high ...' | | | Monday, 24 November 2008 by www.businesswire.com | |
|
|
|
| | | ''ATLANTA--(BUSINESS WIRE)--Aurora Imaging Technology Inc. today announced that for the first time, two Aurora® 1.5Tesla Dedicated Breast MRI Systems will be available to patients at one health care facility, greatly improving the quality of care and ...' | | | Monday, 22 September 2008 by www.businesswire.com | |
|
|
|
| | | ''ST. LOUIS, Mo.--(BUSINESS WIRE)--Metro Imaging in St. Louis, Mo., is the first outpatient imaging center in the nation to install Hitachi's OASIS™ high-field magnetic resonance (MR) imaging system at its South County location, 13303 Tesson Ferry Road. ...' | | | Wednesday, 10 September 2008 by www.businesswire.com | |
|
|
|
| | | ''Blacksburg, Va. - Virginia Tech chemistry Professor Harry Dorn has developed a new area of fullerene chemistry that may be the backbone for development of molecular semiconductors and quantum computing applications. Dorn plays with the hollow carbon ...' | | | Tuesday, 9 September 2008 by www.brightsurf.com | |
|
|
|
| | | ''MELVILLE, NEW YORK, July 22, 2008 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™ announced today that on July 15, 2008, it filed a request for a hearing with the NASDAQ Listing Qualifications Panel. The request has been granted. FONAR ...' | | | Tuesday, 22 July 2008 by www.fonar.com | |
|
|
|
| | | ''NEW YORK, July 2 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. has announced the possibility of a new application for its PulmoBind Molecular Imaging technology. The PulmoBind product candidates being developed by Pulmo BioTech subsidiary PulmoScience ...' | | | Thursday, 3 July 2008 by www.biospace.com | |
|
|
|
| | | ''The understanding of the pathogenesis of nephrogenic systemic fibrosis (NSF) and its link with gadolinium-containing contrast agents is still in an early stage. The studies by Wiginton et al. [1] and Golding and Provenzale [2] in the April 2008 issue of ...' | | | Friday, 27 June 2008 by www.ajronline.org | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
When you are right you cannot be too radical; when you are wrong, you cannot
be too conservative.
- Martin Luther King Jr. |
|
|
News
top
